PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Medicine, Division of Infectious Diseases, Center for Antibody Therapeutics, University of Pittsburgh Medical School, Pittsburgh, PA 15261; LIWEI171@pitt.edu mit666666@pitt.edu.\', \'Department of Medicine, Division of Infectious Diseases, Center for Antibody Therapeutics, University of Pittsburgh Medical School, Pittsburgh, PA 15261.\', \'Department of Microbiology and Immunology, Centers for Biodefense and Emerging Diseases, Galveston National Laboratory, Galveston, TX 77550.\', \'Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599.\', \'Department of Veterinary Microbiology, Vaccine and Infectious Disease Organization-International Vaccine Centre, University of Saskatchewan, Saskatoon, SK S7N 5E3, Canada.\', \'Abound Bio, Pittsburgh, PA 15219.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1073/pnas.2010197117
?:doi
?:hasPublicationType
?:journal
  • Proceedings of the National Academy of Sciences of the United States of America
is ?:pmid of
?:pmid
?:pmid
  • 33139569
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 6.092
?:rankingScore_hIndex
  • 675
is ?:relation_isRelatedTo_publication of
?:title
  • Rapid identification of a human antibody with high prophylactic and therapeutic efficacy in three animal models of SARS-CoV-2 infection.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all